MAPK9 and glioma: EGFR induced radioresistance of glioma cells via triggering the PI3K–Akt and MEK–ERK pathways and attenuated cetuximab-mediated radiosensitization of squamous cell carcinoma cells via the JIP-4/JNK2 signaling pathway (26, 38).